脑机接口产品又有新突破，植入者实现无线自由

Group 1 - Brain Tiger Technology announced the completion of the first clinical trial for its fully implanted, wireless, and fully functional brain-computer interface (BCI) product, which is the first in China and the second globally with an internal battery [1] - The BCI product allows a patient with complete paralysis below the shoulders for 8 years to browse the web and play games after training, showcasing significant advancements in user capabilities [1] - The product eliminates the risk of infection associated with traditional external systems by having all core modules, including the battery, fully implanted, and it offers true "wireless freedom" through integrated wireless power and data transmission [1] Group 2 - According to Huafu Securities, the global brain-computer interface market is projected to reach approximately $2.62 billion in 2024, $2.94 billion in 2025, and is expected to grow to $12.4 billion by 2034, with a compound annual growth rate (CAGR) of 17.35% over the next decade [1] - The Chinese brain-computer interface market is estimated to be 3.2 billion yuan in 2024, with expectations to reach 6.14 billion yuan by 2028 [1] - UCloud and Brain Tiger Technology are collaborating on a "speech synthesis brain-computer interface product" as part of Shanghai's 2024 "Technology Innovation Action Plan" [2] - Weisi Medical has been focusing on the non-invasive brain-computer interface field and has developed core technologies for high-precision EEG signal acquisition, environmental interference correction, neural feature extraction, and machine learning decoding algorithms [2]